The prohibitin-binding compound fluorizoline suppresses cell proliferation of MCF7 breast cancer cells.

○Hiroko Takagi

[28P01-252S] The prohibitin-binding compound fluorizoline suppresses cell proliferation of MCF7 breast cancer cells.

○Hiroko Takagi¹, Chiami Moyama¹, Keiko Taniguchi², Shota Ando¹, Kota Ando¹, Ryohei Matsuda¹, Momoka Endo¹, Hiromi Ii ¹, Susumu Kageyama³, Susumu Nakata¹ (1. Department of Clinical Oncology, Kyoto Pharmaceutical Univ., 2. Department of Drug Discovery Medicine, Kyoto Prefectural Univ. of Medicine, 3. Department of Urology, Shiga Univ. of Medical Science)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[28P01] 医薬品情報②/TDM・投与設計③
薬物療法（基礎・がん）/医療薬学（その他）③
病態生理学（がん）②

[28P01-252S] The prohibitin-binding compound fluorizoline suppresses cell proliferation of MCF7 breast cancer cells.

Password

Presentation information

[28P01] 医薬品情報②/TDM・投与設計③薬物療法（基礎・がん）/医療薬学（その他）③病態生理学（がん）②

[28P01-252S] The prohibitin-binding compound fluorizoline suppresses cell proliferation of MCF7 breast cancer cells.

Password

[28P01] 医薬品情報②/TDM・投与設計③
薬物療法（基礎・がん）/医療薬学（その他）③
病態生理学（がん）②